Company intelligence / Profile preview
Antion Biosciences
Geneva, GE, Switzerlandantionbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Antion has demonstrated preclinical proof-of-concept for its allogeneic anti-CD7 CAR T-cell product (“miCAR7”), showing highly effective tumor control in animal models. The company’s technology enables simultaneous modulation of multiple genes from a single construct, resulting in high purity (>99%) engineered cells with enhanced safety profiles. Additional preclinical data support the development of allogeneic CAR-T solutions for HIV and other indications.
- Therapeutic areas
- OncologyImmunologyNeurologyInfectious Diseases
- Modalities
- Allogeneic cell therapies (CAR T-cells)Gene-modified cell therapiesNucleic acid drugs
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Collaboration with Allogene Therapeutics to validate platform technology; milestone achievements reported March 2024.
Beyond the preview
Go deeper on Antion Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antion Biosciences.